Esophageal Cancer Therapeutics Market Analysis 2024-2032: Key Players Include AstraZeneca, Takeda, Pfizer, Novartis, Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Sanofi, AbbVie, and GlaxoSmithKline

The esophageal cancer market is expected to grow at a CAGR of 9% from 2024 to 2032, reaching a market value of USD 2.8 billion by 2032. The growth is driven by the increasing incidence of esophageal cancer, particularly in aging populations, and the need for advanced...